Obalon Therapeutics (Obalon Therapeutics) Total Equity : $10.10 Mil (As of Mar. 2021)

View and export this data going back to 2016. Start your Free Trial

What is Obalon Therapeutics Total Equity?

Obalon Therapeutics's total equity for the quarter that ended in Mar. 2021 was $10.10 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Obalon Therapeutics Total Equity Historical Data

The historical data trend for Obalon Therapeutics's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Obalon Therapeutics Total Equity Chart

Obalon Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Total Equity

Get a 7-Day Free Trial

64.31

35.11

13.11

15.85

4.67

Obalon Therapeutics Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
Total Equity	Get a 7-Day Free Trial															11.07	7.18	5.92	4.67	10.10

Obalon Therapeutics Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Obalon Therapeutics's Total Equity for the fiscal year that ended in Dec. 2020 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2020 )	-	Total Liabilities(Q: Dec. 2020 )
	=	10.617	-	5.952
	=	4.67

Obalon Therapeutics's Total Equity for the quarter that ended in Mar. 2021 is calculated as

Total Equity	=	Total Assets(Q: Mar. 2021 )	-	Total Liabilities(Q: Mar. 2021 )
	=	17.343	-	7.245
	=	10.10

Obalon Therapeutics Total Equity Related Terms

Thank you for viewing the detailed overview of Obalon Therapeutics's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Obalon Therapeutics (Obalon Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Obalon Therapeutics Inc (NAS:OBLN) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

5421 Avenida Encinas, Suite F, Carlsbad, CA, USA, 92008

Website

https://www.obalon.com

Obalon Therapeutics Inc is a medical device company that focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Its product includes Obalon Balloon System. Geographically, it derives all of its revenue from the United States.

Executives

Raymond V Dittamore	director	P O BOX 2050, GLENWOOD SPRINGS CO 81602
William J. Plovanic	director	C/O OBALON THERAPEUTICS, INC., 5421 AVENIDA ENCINAS, SUITE F, CARLSBAD CA 92008
Sharon Stevenson	director	C/O OBALON THERAPEUTICS, INC., 5421 AVENIDA ECINAS, SUITE F, CARLSBAD CA 92008
Douglas Fisher	director	587 PATROL RD, WOODSIDE CA 94062
Lesley H Howe	director
Kim P. Kamdar	director	C/O DOMAIN ASSOCIATES, L.L.C., ONE PALMER SQUARE, SUITE 515, PRINCETON NJ 08542
Andrew P Rasdal	director, officer: President, CEO & Exec Chairman	C/O DEXCOM, INC., 5555 OBERLIN DRIVE, SAN DIEGO CA 92121
Nooshin Hussainy	officer: Chief Financial Officer	C/O OBALON THERAPEUTICS, INC., 5421 AVENIDA ENCINAS, SUITE F, CARLSBAD CA 92008
Mark Brister	officer: Chief Technology Officer	C/O DEXCOM, INC., 5555 OBERLIN DRIVE, SAN DIEGO CA 92121
Robert J Macdonald	officer: Chief Retail Officer	C/O OBALON THERAPEUTICS INC., 5421 AVENIDA ENCINAS, SUITE F, CARLSBAD CA 92008
Amy Vandenberg	officer: Chief Clinical & Reg Officer	C/O OBALON THERAPEUTICS, INC., 5421 AVENIDA ENCINAS, SUITE F, CARLSBAD CA 92008
Nicole Vitullo	10 percent owner	3030 SCIENCE PARK ROAD, SAN DIEGO CA 92121
Brian H Dovey	10 percent owner	ONE PALMER SQUARE, PRINCETON NJ 08542
Arnold L Oronsky	10 percent owner	C/O INTERWEST PARTNERS, 467 FIRST STREET SUITE 201, LOS ALTOS CA 94022
Gilbert H Kliman	10 percent owner	C/O INTERWEST PARTNERS, 467 FIRST STREET SUITE 201, LOS ALTOS CA 94022